Literature DB >> 3917752

Mixing short and intermediate acting insulins in the syringe: effect on postprandial blood glucose concentrations in type I diabetics.

R J Heine, H J Bilo, A C Sikkenk, E A van der Veen.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3917752      PMCID: PMC1417929          DOI: 10.1136/bmj.290.6463.204-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


× No keyword cloud information.
  2 in total

1.  [Crystalline and amorphous insulin and zinc compounds with prolonged action].

Authors:  K HALLAS-MØLLER; K PETERSEN; J SCHLICHTKRULL
Journal:  Ugeskr Laeger       Date:  1951-12-27

2.  Absorption kinetics and biologic effects of subcutaneously injected insulin preparations.

Authors:  M Berger; H J Cüppers; H Hegner; V Jörgens; P Berchtold
Journal:  Diabetes Care       Date:  1982 Mar-Apr       Impact factor: 19.112

  2 in total
  5 in total

1.  Effect of storage temperature of insulin on pharmacokinetics and pharmacodynamics of insulin mixtures injected subcutaneously in subjects with type 1 (insulin-dependent) diabetes mellitus.

Authors:  G Perriello; E Torlone; S Di Santo; C Fanelli; P De Feo; F Santeusanio; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1988-11       Impact factor: 10.122

2.  Mixing short and intermediate acting insulins: effect on postprandial blood glucose concentrations.

Authors:  R Heine
Journal:  Br Med J (Clin Res Ed)       Date:  1985-05-18

3.  Human isophane or lente insulin? A double blind crossover trial in insulin dependent diabetes mellitus.

Authors:  D M Gibb; A B Foot; B May; H Parish; S Strang; D B Grant; D B Dunger
Journal:  Arch Dis Child       Date:  1990-12       Impact factor: 3.791

Review 4.  Insulin-dependent (type I) diabetes mellitus.

Authors:  W Rodger
Journal:  CMAJ       Date:  1991-11-15       Impact factor: 8.262

Review 5.  Features, prevention and management of acute overdose due to antidiabetic drugs.

Authors:  D F Moore; D F Wood; G N Volans
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.